Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007-2017-insights from a national registry.
Lang CN, Kaier K, Zotzmann V, Stachon P, Pottgiesser T, von Zur Muehlen C, Zehender M, Duerschmied D, Schmid B, Bode C, Wengenmayer T, Staudacher DL. Lang CN, et al. Among authors: stachon p. Clin Res Cardiol. 2021 Sep;110(9):1421-1430. doi: 10.1007/s00392-020-01781-z. Epub 2020 Nov 30. Clin Res Cardiol. 2021. PMID: 33258007 Free PMC article.
Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.
Missiou A, Köstlin N, Varo N, Rudolf P, Aichele P, Ernst S, Münkel C, Walter C, Stachon P, Sommer B, Pfeifer D, Zirlik K, MacFarlane L, Wolf D, Tsitsikov E, Bode C, Libby P, Zirlik A. Missiou A, et al. Among authors: stachon p. Circulation. 2010 May 11;121(18):2033-44. doi: 10.1161/CIRCULATIONAHA.109.895037. Epub 2010 Apr 26. Circulation. 2010. PMID: 20421522 Free PMC article.
TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation.
Missiou A, Rudolf P, Stachon P, Wolf D, Varo N, Aichele P, Colberg C, Hoppe N, Ernst S, Münkel C, Walter C, Sommer B, Hilgendorf I, Nakano H, Bode C, Zirlik A. Missiou A, et al. Among authors: stachon p. Circ Res. 2010 Sep 17;107(6):757-66. doi: 10.1161/CIRCRESAHA.110.219295. Epub 2010 Jul 22. Circ Res. 2010. PMID: 20651286 Clinical Trial.
Binding of CD40L to Mac-1's I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis--but does not affect immunity and thrombosis in mice.
Wolf D, Hohmann JD, Wiedemann A, Bledzka K, Blankenbach H, Marchini T, Gutte K, Zeschky K, Bassler N, Hoppe N, Rodriguez AO, Herr N, Hilgendorf I, Stachon P, Willecke F, Duerschmied D, von zur Muhlen C, Soloviev DA, Zhang L, Bode C, Plow EF, Libby P, Peter K, Zirlik A. Wolf D, et al. Among authors: stachon p. Circ Res. 2011 Nov 11;109(11):1269-79. doi: 10.1161/CIRCRESAHA.111.247684. Epub 2011 Oct 13. Circ Res. 2011. PMID: 21998326 Free PMC article.
Inflammatory mechanisms in atherosclerosis.
Wolf D, Stachon P, Bode C, Zirlik A. Wolf D, et al. Among authors: stachon p. Hamostaseologie. 2014;34(1):63-71. doi: 10.5482/HAMO-13-09-0050. Epub 2013 Dec 17. Hamostaseologie. 2014. PMID: 24343521 Review.
Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.
Stachon P, Kaier K, Milde S, Pache G, Sorg S, Siepe M, von zur Mühlen C, Zirlik A, Beyersdorf F, Langer M, Zehender M, Bode C, Reinöhl J. Stachon P, et al. Eur Heart J Cardiovasc Imaging. 2015 Jul;16(7):731-7. doi: 10.1093/ehjci/jev055. Epub 2015 Mar 10. Eur Heart J Cardiovasc Imaging. 2015. PMID: 25759083 Free PMC article.
Dual pathway therapy in acute coronary syndrome.
Stachon P, Ahrens I, Bode C, Zirlik A. Stachon P, et al. J Thromb Thrombolysis. 2016 Aug;42(2):254-60. doi: 10.1007/s11239-015-1306-3. J Thromb Thrombolysis. 2016. PMID: 26660521 Review.
Asymptomatic atrial fibrillation and risk of stroke.
Stachon P, Ahrens I, Faber T, Bode C, Zirlik A. Stachon P, et al. Panminerva Med. 2015 Dec;57(4):211-5. Epub 2016 Jan 12. Panminerva Med. 2015. PMID: 26756697 Free article. Review.
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.
Lindau A, Härdtner C, Hergeth SP, Blanz KD, Dufner B, Hoppe N, Anto-Michel N, Kornemann J, Zou J, Gerhardt LM, Heidt T, Willecke F, Geis S, Stachon P, Wolf D, Libby P, Swirski FK, Robbins CS, McPheat W, Hawley S, Braddock M, Gilsbach R, Hein L, von zur Mühlen C, Bode C, Zirlik A, Hilgendorf I. Lindau A, et al. Among authors: stachon p. Basic Res Cardiol. 2016 Mar;111(2):20. doi: 10.1007/s00395-016-0535-8. Epub 2016 Feb 18. Basic Res Cardiol. 2016. PMID: 26891724 Free PMC article.
94 results